Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2016 | Hua Medicine | $50.0M Series C | Harvest Investments | ARCH Venture Partners, Flagship Ventures, F-Prime Capital Partners, Meritech Capital Partners, Venrock, Ally Bridge Group, Fidelity Management & Research Company, Frontline BioVentures Arch, TF Capital, WuXi Healthcare Ventures |
| Jan 1, 2015 | Hua Medicine | $25.0M Series B | Ally Bridge Group | ARCH Venture Partners, Flagship Ventures, F-Prime Capital Partners, Meritech Capital Partners, Venrock, Fidelity Management & Research Company, Frontline BioVentures, TF Capital, WuXi Healthcare Ventures |
| Jul 11, 2011 | Xtreme Power Conversion | $16.4M Other Equity | — | Bessemer Venture Partners, SkyLake Equity Partners, Spring Ventures, The Dow Chemical Company |
| Jul 27, 2010 | Xtreme Power Conversion | $29.5M Series C | Walter Schindler, The Dow Chemical Company | — |